Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
BJU International|February 26, 2009
Fulguration of the lumen does not improve vasectomy sterilization ratesNicholas P Munro, Sanjeev Kotwal, Ng K Gogoi, et al.Journal of Immunological Methods|February 16, 2010
A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodiesMartina L Jones, Therese Seldon, Matthew Smede, et al.International Journal of Cancer|September 23, 2006
Urinary biomarker profiling in transitional cell carcinomaNicholas P Munro, David A Cairns, Paul Clarke, et al.Molecular and Cellular Biology|March 10, 2001
RNA trafficking signals in human immunodeficiency virus type 1A J Mouland, H Xu, H Cui, et al.Biomaterials|August 3, 2010
Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free mediaAndrew B J Prowse, Michael R Doran, Justin J Cooper-White, et al.The Journal of Biological Chemistry|February 22, 2021
Mutational and biophysical robustness in a prestabilized monobodyPeter G Chandler, Li Lynn Tan, Benjamin T Porebski, et al.Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.Ebiomedicine|October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.The Journal of Infectious Diseases|November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.Nature Structural & Molecular Biology|July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.Pageof 13